{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:49:02Z","timestamp":1761896942452},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Capital Characteristic Clinic Project","award":["Z161100000516011"],"award-info":[{"award-number":["Z161100000516011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13287-018-1089-5","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T14:25:42Z","timestamp":1545315942000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Remission of HIV-related na\u00efve and high-risk Burkitt\u2019s lymphoma treated by autologous stem cell transplantation plus cART"],"prefix":"10.1186","volume":"9","author":[{"given":"Haiyan","family":"Min","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqin","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaopei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingqi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xicheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruonan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,20]]},"reference":[{"key":"1089_CR1","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1126\/science.272.5265.1167","volume":"272","author":"JW Mellors","year":"1996","unstructured":"Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996;272:1167\u201370.","journal-title":"Science"},{"key":"1089_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cancergen.2013.05.001","volume":"206","author":"Y Chen","year":"2013","unstructured":"Chen Y, Dave BJ, Zhu X, Chan WC, Iqbal J, Sanger WG, et al. Differences in the cytogenetic alteration profiles of diffuse large B-cell lymphoma among Chinese and American patients. Cancer Genet. 2013;206:183\u201390.","journal-title":"Cancer Genet"},{"key":"1089_CR3","doi-asserted-by":"publisher","first-page":"735392","DOI":"10.1155\/2012\/735392","volume":"2012","author":"JA Rodrigo","year":"2012","unstructured":"Rodrigo JA, Hicks LK, Cheung MC, Song KW, Ezzat H, Leger CS, et al. HIV-associated Burkitt lymphoma: good efficacy and tolerance of intensive chemotherapy including CODOX-M\/IVAC with or without rituximab in the HAART Era. Adv Hematol. 2012;2012:735392.","journal-title":"Adv Hematol"},{"key":"1089_CR4","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.3109\/10428194.2012.697559","volume":"53","author":"UD Bayraktar","year":"2012","unstructured":"Bayraktar UD, Ramos JC, Petrich A, Gupta N, Lensing S, Moore PC, et al. Outcome of patients with relapsed\/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999-2008 and treated with curative intent in the AIDS Malignancy Consortium. Leuk Lymphoma. 2012;53:2383\u20139.","journal-title":"Leuk Lymphoma"},{"key":"1089_CR5","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1200\/JCO.2000.18.23.3918","volume":"18","author":"AM Carella","year":"2000","unstructured":"Carella AM, Cavaliere M, Lerma E, Ferrara R, Tedeschi L, Romanelli A, et al. Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma. J Clin Oncol. 2000;18:3918\u201324.","journal-title":"J Clin Oncol"},{"key":"1089_CR6","doi-asserted-by":"crossref","unstructured":"Baker JV, Peng G, Rapkin J, Silverberg MJ, MacArthur RD, Cavert WP, et al. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection. AIDS 2008;22:841\u2013848.","DOI":"10.1097\/QAD.0b013e3282f7cb76"},{"key":"1089_CR7","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/bjc.2015.301","volume":"113","author":"S Venturelli","year":"2015","unstructured":"Venturelli S, Pria AD, Stegmann K, Smith P, Bower M. The exclusion of people living with HIV (PLWH) from clinical trials in lymphoma. Br J Cancer. 2015;113:861\u20133.","journal-title":"Br J Cancer"},{"key":"1089_CR8","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1182\/blood-2011-08-373738","volume":"119","author":"K Dunleavy","year":"2012","unstructured":"Dunleavy K, Wilson WH. How I treat HIV associate lymphoma. Blood. 2012;119:3245\u201355.","journal-title":"Blood"},{"key":"1089_CR9","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1200\/JCO.1996.14.11.3026","volume":"14","author":"JA Sparano","year":"1996","unstructured":"Sparano JA, Wiernik PH, Hu X, Schwartz EL, Soeiro R, Henry DH, et al. Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin\u2019s lymphoma. J Clin Oncol. 1996;14:3026\u201335.","journal-title":"J Clin Oncol"},{"key":"1089_CR10","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1200\/JCO.2001.19.8.2171","volume":"19","author":"L Ratner","year":"2001","unstructured":"Ratner L, Lee J, Tang S, Redden D, Hamzeh F, Herndier B, et al. Chemotherapy for human immunodeficiency virus-associated non-Hodgkin\u2019s lymphoma in combination with highly active antiretroviral therapy. J Clin Oncol. 2001;19:2171\u20138.","journal-title":"J Clin Oncol"},{"key":"1089_CR11","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1200\/JCO.2003.06.039","volume":"21","author":"A Re","year":"2003","unstructured":"Re A, Cattaneo C, Michieli M, Casari S, Spina M, Rupolo M, et al. High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy. J Clin Oncol. 2003;21:4423\u20137.","journal-title":"J Clin Oncol"},{"key":"1089_CR12","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1182\/blood-2015-08-664706","volume":"128","author":"JC Alvarnas","year":"2016","unstructured":"Alvarnas JC, Le Rademacher J, Wang Y, Little RF, Akpek G, Ayala E, et al. Autologous hematopoietic cell transplantation for HIV-associated lymphoma: results of the BMT CTN 0803\/AMC 071 trial. Blood. 2016;128:1050\u20138.","journal-title":"Blood"},{"key":"1089_CR13","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1182\/blood-2014-03-561985","volume":"124","author":"F Rhee van","year":"2014","unstructured":"van Rhee F, Giralt S, Barlogie B. The future of autologous stem cell transplantation in myeloma. Blood. 2014;124:328\u201333.","journal-title":"Blood"},{"key":"1089_CR14","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/ajh.25112","volume":"93","author":"JJ Castillo","year":"2018","unstructured":"Castillo JJ, Beltran BE, Miranda RN, Young KH, Chavez JC, Sotomayor EM. EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2018 update on diagnosis, risk-stratification and management. Am J Hematol. 2018;93:953\u201362.","journal-title":"Am J Hematol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-018-1089-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-018-1089-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-018-1089-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:23:16Z","timestamp":1576801396000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-018-1089-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1089"],"URL":"https:\/\/doi.org\/10.1186\/s13287-018-1089-5","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"2 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Peking University, China. Written informed consent was obtained from our patients before hematopoietic stem cell transplantation (HSCT).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"353"}}